Jeffrey Becker
Oprichter bij Bexson Biomedical, Inc.
Profiel
Jeffrey Becker is the founder of Bexson Biomedical, Inc. He currently works as a Venture Partner at Noetic Psychedelic.
He completed his undergraduate degree at UC Berkeley School of Public Health.
Actieve functies van Jeffrey Becker
Bedrijven | Functie | Begin |
---|---|---|
Bexson Biomedical, Inc.
Bexson Biomedical, Inc. BiotechnologyHealth Technology Bexson Biomedical, Inc. is a research stage company based in Santa Barbara, CA. The company is focused on developing BB106, a ketamine therapy for pain management and mental health disorders. The company is also applying their proprietary delivery platform to several psychedelic and non-psychedelic compounds to reduce suffering caused by pain, addiction, and mental health conditions. The company was founded by Jeffrey Becker and Gregg Peterson has been the CEO of the company since 2019. | Oprichter | - |
Noetic Psychedelic
Noetic Psychedelic Investment ManagersFinance Noetic Psychedelic (Noetic) is a venture capital firm, a subsidiary of Grey House Partners GP, Inc. founded in 2019. The firm is headquartered in Toronto, Canada. | Private Equity Investor | - |
Opleiding van Jeffrey Becker
UC Berkeley School of Public Health | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Noetic Psychedelic
Noetic Psychedelic Investment ManagersFinance Noetic Psychedelic (Noetic) is a venture capital firm, a subsidiary of Grey House Partners GP, Inc. founded in 2019. The firm is headquartered in Toronto, Canada. | Finance |
Bexson Biomedical, Inc.
Bexson Biomedical, Inc. BiotechnologyHealth Technology Bexson Biomedical, Inc. is a research stage company based in Santa Barbara, CA. The company is focused on developing BB106, a ketamine therapy for pain management and mental health disorders. The company is also applying their proprietary delivery platform to several psychedelic and non-psychedelic compounds to reduce suffering caused by pain, addiction, and mental health conditions. The company was founded by Jeffrey Becker and Gregg Peterson has been the CEO of the company since 2019. | Health Technology |